Farmahem’s Post

𝐋𝐢𝐯𝐞 𝐖𝐞𝐛𝐢𝐧𝐚𝐫 "𝐑𝐞𝐪𝐮𝐢𝐫𝐞𝐦𝐞𝐧𝐭𝐬 𝐨𝐟 𝐔𝐒𝐏 𝐚𝐧𝐝 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐨𝐩𝐨𝐞𝐢𝐚" USP and Ph. Eur. chapters are legally binding for all pharmaceutical companies in the US and Europe as well as companies that import pharmaceutical products to the US and Europe. As such, USP and Ph. Eur. requirements are enforced in the framework of GMP audits performed by regulatory bodies. Both chapters focus on lifecycle management of analytical balances used for quality control of drugs and state that calibration is mandatory. In this webinar we will help to guide you through the topic of European Pharmacopoeia Chapter 2.1.7 and USP in relation to weighing. Register now: https://lnkd.in/dCXsFSUP

🌟 Join Mettler Toledo's Upcoming Webinar: The Requirements of USP and European Pharmacopoeia! 🌟 🗓 Date: December 12, 2024 🕒 Time: 15:00 CET ⏳ Duration: 30 minutes Don't miss this excellent opportunity to gain valuable insights into important regulatory requirements and best practices related to weighing in the pharmaceutical industry. 👉 Register now to secure your spot: The Requirements of USP and European Pharmacopoeia - METTLER TOLEDO #USP #PharmaceuticalIndustry #Webinar

USP and Ph. Eur. chapters are legally binding for all pharmaceutical companies in the US and Europe as well as companies that import pharmaceutical products to the US and Europe. As such, USP and Ph. Eur. requirements are enforced in the framework of GMP audits performed by regulatory bodies. Both chapters focus on lifecycle management of analytical balances used for quality control of drugs and state that calibration is mandatory. In this webinar we will help to guide you through the topic of European Pharmacopoeia Chapter 2.1.7 and USP in relation to weighing. Register now: The Requirements of USP and European Pharmacopoeia (mt.com) https://lnkd.in/dCXsFSUP

Top Barrier Technology in Pharmaceutical industry

EU – GMP PRODUCT REGISTRATION: In-House Development or Acquiring Existing Registrations ? ⭐ In recent years, the demand for higher-quality pharmaceutical products has driven an increasing need for manufacturers to adhere to EU-GMP standards. While EU-GMP registration grants access to the European market and facilitates regulatory inspections, it demands strict compliance with EU regulations. 🤔 But should pharmaceutical manufacturers develop products in-house or acquire existing EU-GMP registered dossiers ? 🔎 What factors help you choose the right option for your company? 💡 Thinking about EU-GMP registration? Weigh the pros and cons of in-house development vs. acquiring an existing dossier. Our experts can help you make the best decision for your business. 👉 Please refer to the details in this article of SEN Pharma: https://lnkd.in/gD5UQmsz

The EMA Quality Innovation Group has published its report from on its Listen-and-Learn Focus Group on Process Models. 120 participants from industry, academia and regulatory authorities, including representatives from US FDA, PMDA and Swissmedic discussed and exchanged views on the QIG preliminary considerations on pharmaceutical process models and its applicability to case studies. report-3rd-listen-learn-focus-group-llfg-meeting-quality-innovation-group-qig_en.pdf Preliminary QIG Considerations regarding Pharmaceutical Process Models   🔗 Find out more - #Quality Innovation Group #MedicinesInnovation #QualityInnovation

Report on the State of Pharmaceutical Quality for year 2023 Office of Pharmaceutical Quality an arm of FDA Center For Drug Evaluation and Research (CDER) assures that drugs legally marketed in the U.S. are safe and effective, and meet quality standards. FY2023 Key Takeaways: *CDER’s Site Catalog has more than 4,800 manufacturing sites5 globally, with almost 42% of sites located in the U.S.  *There were 776 drug quality assurance inspections, over 40% more than the 548 accomplished in FY2022. *There were 187 Mutual Recognition Agreement (MRA) partner inspections classified under the MRAs, the highest number achieved to date. Federation of Pharma Entrepreneurs

BEST PRACTICES FOR CGMP STORAGE AND DISTRIBUTION IN THE PHARMACEUTICAL INDUSTRY In the highly regulated pharmaceutical sector, adhering to current Good Manufacturing Practices (cGMP) is crucial for ensuring the safety, efficacy, and quality of drugs. This detailed guide outlines the pivotal strategies for maintaining cGMP… Check out the article here: https://lnkd.in/e-7ashdb #CGMPInnovation #PharmaTech #SupplyChainRevolution #LogisticsInnovation #TechDrivenCGMP

The key factor spurring the pharmaceutical processing seals market growth is the presence of stringent regulations implied on pharmaceutical manufacturers to ensure high-quality sealing solutions. Regulatory agencies such as the FDA, EMA, and similar bodies worldwide enforce stringent standards for pharmaceutical manufacturing driving the demand for seals that comply with these regulations to ensure product safety and quality.  Uncover market growth opportunities @ https://lnkd.in/dzfTtgM8 #gvr #pharmaceuticalprocessingseals #pharmacy #FDA #EMA #marketanalysis #researchreport

The current quality and safety standards for pharmaceutical products (active ingredients or finished products) requires the generation of many lab-based measurement values to allow further human trials or final release. However, regulatory authorities have dealt with numerous situations of tampered non-clinical (toxicological and pharmacological) laboratory studies required for the authorization of new drugs. In this article, we explain an overview of GLP in general, with an emphasis on its application in the pharmaceutical industry: https://hubs.ly/Q02s4h5v0